23.91
전일 마감가:
$24.40
열려 있는:
$24.4
하루 거래량:
937.06K
Relative Volume:
0.58
시가총액:
$1.62B
수익:
$2.76B
순이익/손실:
$-358.70M
주가수익비율:
-4.8109
EPS:
-4.97
순현금흐름:
$-35.90M
1주 성능:
+4.82%
1개월 성능:
-22.42%
6개월 성능:
-44.25%
1년 성능:
-42.25%
Quidelortho Corporation Stock (QDEL) Company Profile
명칭
Quidelortho Corporation
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
QDEL
Quidelortho Corporation
|
23.91 | 1.59B | 2.76B | -358.70M | -35.90M | -4.97 |
![]()
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
2024-12-10 | 개시 | Jefferies | Hold |
2024-09-19 | 재개 | UBS | Neutral |
2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
2022-09-19 | 개시 | Citigroup | Neutral |
2022-07-20 | 개시 | UBS | Sell |
2022-06-17 | 재개 | JP Morgan | Neutral |
2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2018-10-23 | 재개 | Raymond James | Strong Buy |
2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-01-22 | 재확인 | Barclays | Overweight |
2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2017-04-25 | 재확인 | Canaccord Genuity | Hold |
2017-02-17 | 개시 | CL King | Neutral |
2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2016-02-18 | 재확인 | Barclays | Overweight |
2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2016-01-08 | 재확인 | Canaccord Genuity | Buy |
2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2015-09-02 | 개시 | Barclays | Overweight |
2013-07-31 | 재확인 | Canaccord Genuity | Buy |
2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corporation 주식(QDEL)의 최신 뉴스
Earnings Release: Here's Why Analysts Cut Their QuidelOrtho Corporation (NASDAQ:QDEL) Price Target To US$43.14 - 富途牛牛
Will QuidelOrtho's (QDEL) Renewed Cost Discipline Strengthen Its Long-Term Growth Story? - simplywall.st
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
QuidelOrtho narrows China outlook to mid-single-digit growth as cost actions drive margin gains - MSN
QuidelOrtho (QDEL) Analyst Rating Update: UBS Lowers Price Target | QDEL Stock News - GuruFocus
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand - MSN
UBS Cuts Price Target on QuidelOrtho to $26 From $29, Maintains Neutral Rating - MarketScreener
Should Value Investors Buy QuidelOrtho (QDEL) Stock? - Yahoo Finance
QuidelOrtho 2025 Q2 Earnings Widens Losses Amid Revenue Decline - AInvest
QuidelOrtho Corporation (NASDAQ:QDEL) Q2 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho Q2 Revenue Beats Estimate, EPS Turns Positive Amid Restructuring Costs. - AInvest
QuidelOrtho’s Earnings Call: Mixed Sentiment with Global Growth - TipRanks
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats - AOL.com
QuidelOrtho Stock Soars 10.85% on Q2 Earnings Beat - AInvest
Citi Adjusts QuidelOrtho (QDEL) Price Target, Maintains Buy Rati - GuruFocus
QuidelOrtho 2025 Q2 Earnings Deeper Losses Amid Revenue Decline - AInvest
QuidelOrtho revenue decreases to USD 614M in Q2 2025 - Medical Buyer
QuidelOrtho: Q2 Earnings Snapshot - Huron Daily Tribune
QuidelOrtho Corp SEC 10-Q Report - TradingView
QuidelOrtho's Q2 Financial Performance and Future OutlookNews and Statistics - IndexBox
QuidelOrtho Topped Estimates But Still Posted A Net Loss - Finimize
QuidelOrtho's Strategic Cost-Cutting and Margin Expansion: A Hidden Opportunity in a Declining Revenue Environment? - AInvest
QuidelOrtho Fiscal Q2 Swings to Adjusted Earnings, Revenue Falls - MarketScreener
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
QuidelOrtho's 2025 Q2 Earnings Call: Key Contradictions in COVID Revenue, Tariffs, and China Growth - AInvest
QuidelOrtho Corporation 2025 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) - Seeking Alpha
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats - The Motley Fool
QuidelOrtho Reports Q2 2025 Financial Results - TipRanks
QuidelOrtho Q2 2025 slides: EPS soars 271% despite revenue decline By Investing.com - Investing.com Nigeria
QuidelOrtho Q2 2025 slides: EPS soars 271% despite revenue decline - Investing.com
Earnings call transcript: Quidel Ortho’s Q2 2025 EPS beats forecast by 7900% - Investing.com Canada
QuidelOrtho’s (NASDAQ:QDEL) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars - uk.finance.yahoo.com
QuidelOrtho Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Quidel shares soar as Q2 results beat estimates, cost-saving initiatives pay off - Investing.com Nigeria
QuidelOrtho's Strategic Reimagining: A Deep Dive into Growth, Innovation, and Market Resilience - AInvest
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q2 Adjusted EPS $0.12 per Share, vs. FactSet Est of $0.00 - MarketScreener
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q2 Revenue $613.9M, vs. FactSet Est of $611.1M - MarketScreener
QuidelOrtho Reports Second Quarter 2025 Financial Results - Yahoo Finance
QuidelOrtho Corporation (QDEL): A Bull Case Theory - Insider Monkey
QuidelOrtho (QDEL) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
What drives QuidelOrtho Corporation stock priceAchieve rapid wealth accumulation through smart investing - Jammu Links News
QuidelOrtho Corporation Stock Analysis and ForecastMaximize your portfolio’s growth potential - Jammu Links News
How does QuidelOrtho Corporation generate profit in a changing economyBuild a diversified portfolio for steady growth - Jammu Links News
Is QuidelOrtho Corporation a growth stock or a value stockUnlock your trading potential today - Jammu Links News
Is QuidelOrtho Corporation a good long term investmentInvest confidently with professional guidance - Jammu Links News
What is QuidelOrtho Corporation company’s growth strategyTremendous wealth creation - Jammu Links News
How strong is QuidelOrtho Corporation company’s balance sheetTremendous growth opportunities - Jammu Links News
What are analysts’ price targets for QuidelOrtho Corporation in the next 12 monthsBuild wealth steadily with proven investment techniques - Jammu Links News
How does QuidelOrtho Corporation compare to its industry peersUnlock exclusive trading strategies for gains - Jammu Links News
What analysts say about QuidelOrtho Corporation stockMaximize gains with professional stock picks - Jammu Links News
Quidelortho Corporation (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):